Paper · 2880852
Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors.
Savola JM and 4 others. J Auton Pharmacol, 1986. Cited by 103 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors. Papers, record 2880852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2880852
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Agonists | Major topic |
| Imidazoles | Major topic |
| Animals | |
| Antihypertensive Agents | |
| Aorta | |
| Blood Pressure | |
| Decerebrate State | |
| Heart Rate | |
| Male | |
| Medetomidine | |
| Posture | |
| Rats | |
| Rats, Inbred Strains | |
| Reflex | |
| Sympathetic Nervous System |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,721,375 | Comparative evaluation of anesthetic effects of medetomidine-midazolam-butorphanol and medetomidine-remimazolam-butorphanol administered subcutaneously and intraperitoneally in C57BL/6J mice. | J Vet Med Sci | 2025 | https://conductscience.org/library/papers/40721375 | PubMed |
| 39,405,508 | Classics in Chemical Neuroscience: Medetomidine. | ACS Chem Neurosci | 2024 | https://conductscience.org/library/papers/39405508 | PubMed |
| 36,185,505 | Effects of intranasal and intramuscular dexmedetomidine in cats receiving total intravenous propofol anesthesia. | Vet World | 2022 | https://conductscience.org/library/papers/36185505 | PubMed |
| 35,891,845 | Comparison of Fentanyl and Dexmedetomidine in Preventing an Increase in Heart Rate During Intubation Among Patients Undergoing General Anesthesia: A Meta-Analysis. | Cureus | 2022 | https://conductscience.org/library/papers/35891845 | PubMed |
| 35,452,606 | General anesthesia globally synchronizes activity selectively in layer 5 cortical pyramidal neurons. | Neuron | 2022 | https://conductscience.org/library/papers/35452606 | PubMed |
| 35,341,088 | Clinical Efficacy of Dexmedetomidine versus Ketamine in Shoulder Dislocation Reduction: A Randomized Clinical Trial Study. | Med J Islam Repub Iran | 2021 | https://conductscience.org/library/papers/35341088 | PubMed |
| 34,912,607 | Acute Colonic Pseudo-Obstruction Following the Use of Dexmedetomidine. | Cureus | 2021 | https://conductscience.org/library/papers/34912607 | PubMed |
| 31,222,586 | Comparing the effect of dexmedetomidine and labetalol on hemodynamic variables in patients undergoing microlaryngoscopy. | Eur Arch Otorhinolaryngol | 2019 | https://conductscience.org/library/papers/31222586 | PubMed |
| 30,559,858 | A Comparison of the Effects of Dexmedetomidine and Propofol in Controlling the Hemodynamic Responses after Intubation: A Double-Blind, Randomized, Clinical Trial Study. | Open Access Maced J Med Sci | 2018 | https://conductscience.org/library/papers/30559858 | PubMed |
| 28,571,235 | Effect of Dexmedetomidine Versus Fentanyl on Haemodynamic Response to Patients Undergoing Elective Laparoscopic Surgery: A Double Blinded Randomized Controlled Study. | J Clin Diagn Res | 2017 | https://conductscience.org/library/papers/28571235 | PubMed |
1 to 10 of 33
See all 33 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2880852
GET https://conductscience.org/api/papers/v1/2880852/cited_by?page=2